课题基金 / 基金详情

Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma

Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma
大规模抗生素分发对沙眼的主要和次要影响
批准号:
8719112
负责人:
Bruce D. Gaynor
金额:
$22.58万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2015-10-31

项目摘要

项目成果

Bruce D. Gaynor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract I have two objectives in seeking a K23 career development award: 1. to improve our understanding of the effects of mass antibiotic distributions for trachoma by conducting an in depth analysis of populations in which trachoma has ostensibly been eliminated and by assessing the positive secondary effects of mass antibiotic treatments on childhood morbidity and mortality; 2. to develop my career as an independent investigator through didactics, mentorship and hands-on research experience in the developing world. I will benefit from the infrastructure of two clinical trials: TANA (Trachoma Amelioration in Northern Amhara, U10 EY016214) and PRET (Partnership for the Rapid Elimination of Trachoma, Gates Foundation, #48027). The WHO launched the GET 2020 (Global Elimination of Trachoma by the year 2020) program to eliminate blinding trachoma, however, the goals have not been met, particularly in hyperendemic communities. Mass treatments have been used in several elimination campaigns and have been found to have unintended secondary effects. I have the following specific aims: SA1: To determine if C. trachomatis infection can be eliminated using rRNA-based nucleic acid amplification compared to DNA-based testing. SA2a: To determine if azithromycin treatments reduce mortality in 1-5 year olds from diarrhea, respiratory disease and malaria. SA2b: To determine if azithromycin treatments effect increases in height, weight, and arm circumference. My goal is to determine if complete elimination is attainable in hyperendemic communities and then to translate these research findings quickly into practice within trachoma programs in general and within the WHO GET 2020 program in particular. Growth indices are a common method for determining the efficacy of mass treatment; developing and testing an instrument for measuring growth and nutrition will provide an important bridge to future studies on integration of trachoma with other neglected tropical diseases (NTD).
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pntd.0002303
发表时间: 2013
期刊: PLoS neglected tropical diseases
影响因子: 3.8
作者: [Liu F, Porco TC, Ray KJ, Bailey RL, Mkocha H, Muñoz B, Quinn TC, Lietman TM, West SK]
通讯作者: West SK
DOI: 10.1016/j.epidem.2013.12.001
发表时间: 2014-03
期刊: EPIDEMICS
影响因子: 3.8
作者: [Liu, Fengchen, Porco, Travis C., Mkocha, Harran A., Munoz, Beatriz, Ray, Kathryn J., Bailey, Robin L., Lietman, Thomas M., West, Sheila K.]
通讯作者: West, Sheila K.
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma
海外基金